Picture of Zhaoke Ophthalmology logo

6622 — Zhaoke Ophthalmology News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Zhaoke Ophthalmology Ltd Says HY Revenue Rmb11.3 Mln

Aug 23 (Reuters) - Zhaoke Ophthalmology Ltd  6622.HK :
    * HY REVENUE RMB11.3 MILLION
    * HY LOSS FOR PERIOD RMB233.8 MILLION VERSUS LOSS RMB161.0
MILLION
    * EXPECT TO RECEIVE APPROVAL FOR COMMERCIALIZATION OF CSA
OPHTHALMIC GEL FROM NMPA IN 2024
    * ACTIVELY PREPARING FOR CHINA IND APPLICATION FOR BRIMOCHOL
PF IN
SECOND HALF OF YEAR AND TO START PHASE I IN 2024

Source text for Eikon:  ID:nHKSWsY8G 
Further company coverage:  6622.HK 

 (Reporting by Adwitiya Srivastava)
 ((Adwitiya.Srivastava@thomsonreuters.com;))

Recent news on Zhaoke Ophthalmology

See all news